Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CANNABIDIOL for Tuberous sclerosis complex: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 241 adverse event reports in the FDA FAERS database where CANNABIDIOL was used for Tuberous sclerosis complex.

Most Reported Side Effects for CANNABIDIOL

Side Effect Reports % Deaths Hosp.
Seizure 4,980 27.3% 74 1,588
Hospitalisation 1,840 10.1% 38 1,830
Off label use 1,636 9.0% 185 770
Product use in unapproved indication 1,585 8.7% 52 233
Diarrhoea 1,356 7.4% 6 152
Death 1,115 6.1% 1,107 80
Somnolence 1,005 5.5% 4 163
Product dose omission issue 895 4.9% 10 213
Drug ineffective 859 4.7% 12 157
Fatigue 715 3.9% 22 89
Weight increased 663 3.6% 2 59
Weight decreased 631 3.5% 10 156
Product administration interrupted 511 2.8% 10 208
Decreased appetite 496 2.7% 4 84
Vomiting 495 2.7% 7 166

Other Indications for CANNABIDIOL

Lennox-gastaut syndrome (7,140) Epilepsy (5,555) Product used for unknown indication (2,899) Seizure (1,436) Partial seizures (1,423) Idiopathic generalised epilepsy (766) Status epilepticus (698) Focal dyscognitive seizures (683) Severe myoclonic epilepsy of infancy (505) Simple partial seizures (241)

Other Drugs Used for Tuberous sclerosis complex

EVEROLIMUS (482) VIGABATRIN (303) SIROLIMUS (131) LAMOTRIGINE (29) TOPIRAMATE (29) LEVETIRACETAM (26) LACOSAMIDE (19) OXCARBAZEPINE (19) VALPROIC ACID (19) CARBAMAZEPINE (15)

Related Pages

CANNABIDIOL Full Profile All Tuberous sclerosis complex Drugs CANNABIDIOL Demographics CANNABIDIOL Timeline